RAB27A and non-small cell lung carcinoma: Overexpression of Rab27a in the non-small-cell lung cancer cell line A549 prompted antitumor immunity, by upregulating the major histocompatibility complex II molecules and promoting the expression of antitumor type I cytokines [69].